VIDAS ANALYZER 99735

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-08-29 for VIDAS ANALYZER 99735 manufactured by Biom?rieux Italia.

Event Text Entries

[53446714] Device not returned to manufacturer.
Patient Sequence No: 1, Text Type: N, H10


[53446715] A customer in the (b)(6) contacted biomerieux to report a qcv (quality control verification) failure (position a1) in association with the vidas analyzer. The customer was advised to take the section offline until service could be obtained. The local field service engineer (fse) visited the customer site to evaluate the vidas issue. The fse cleaned the pump for section a-1. Subsequent qcv testing and pump tests pass. The reported issue was resolved. As the same discrepancy could have occurred with a patient sample since the last successful qcv ((b)(6) 2016), the customer was instructed to conduct a retrospective analysis. Retrospective analysis by the customer determined a total of eight (8) incorrect patient results had been reported since the last successful qcv; seven (7) were confirmed to have had no adverse impact to the patient's state of health, one result is awaiting confirmation by the clinical scientist. The customer reports a delay of up to six (6) days to obtain the correct results following pump cleaning by the fse. There is no indication or report from the laboratory that the failed qcv and subsequent retrospective analysis identified any adverse event related to any patient's state of health. An internal biomerieux investigation will be initiated.
Patient Sequence No: 1, Text Type: D, B5


[63640100] A customer in the (b)(6) contacted biom? Rieux to report a qcv (quality control verification) failure (position a1) in association with the vidas? Analyzer. An internal biom? Rieux investigation was performed. The customer reported a very low value tv1 of 1. 00 instead of greater than 5. 5 for position a1 during the quality control verification (qcv) testing. The customer reported also that external positive controls failed four (4) times on the same position in the instrument. The last conform qcv was performed on (b)(6) 2016. As requested by biom? Rieux, the customer stopped using the section a of the instrument and performed a retrospective analysis between the last conform qcv ((b)(6) 2016) and the failed qcv (02aug2016). Retrospective analysis performed on the position a1 during the relevant period determined eight (8) patient samples may have been affected. Root cause: the qcv failure detected in the section a slot 1 highlighted a possible clog issue in this position. Observation of a qcv failure is not an abnormal behavior. It means that the qcv performed its functional control, which is meant to detect residual risks, that are rare and sudden. Those risks are already present and accepted into the vidas? Systems risk analysis. The vidas pump tester is used to validate or invalidate the presence of a clog in the pump tested. As the result value of the vidas? Pump tester in section a slot 1 was not conformed, it can be determined that a clog is present in the pump of the section a slot 1. Therefore, the root cause was determined to be a clog in the slot 1 of the pump in the section a. As the clog was confirmed, the field service engineer (fse) cleaned the six (6) slots of the section a pump with the pump cleaner and noticed some dust during drilling of the pump at position 1 (which confirmed again the clog issue). After the cleaning, the fse performed a new pump tester on the section a. This time, the results in all slots of the section a were conform indicating the pump issue was resolved and the instrument repaired. After the repair, the fse qualified the instrument by performing two (2) new qcvs on section a of the instrument. Both qcv results were conform. Retrospective analysis: as requested by biom? Rieux, the customer performed a retrospective analysis for tests that had been performed on the slot 1 of the section a of the instrument from the (b)(6) 2016 (date of the last conform qcv) to the (b)(6) 2016 (date of this qcv failure). The retrospective analysis showed that eight (8) patient samples, which had been run on section a slot 1, could have been affected for vidas? Vzg assay, msg assay, hcv assay and txc assay. As detailed in the retrospective analysis document, for the eight (8) patient samples, there were no consequence on the treatment (inappropriate or delayed treatment) and no clinical consequences due to false results (e. G. Hospitalization, delayed or wrong diagnosis, death or injury).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3002769706-2016-00159
MDR Report Key5912447
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-08-29
Date of Report2016-08-02
Date Mfgr Received2016-08-02
Date Added to Maude2016-08-29
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMRS. ELLEN WELTMER
Manufacturer Street595 ANGLUM ROAD
Manufacturer CityHAZELWOOD MO 63042
Manufacturer CountryUS
Manufacturer Postal63042
Manufacturer Phone3147317301
Manufacturer G1BIOM
Manufacturer StreetVIA DI CAMPIGLIANO 58 PONTE-A EMA
Manufacturer CityFIRENZE, ITALY 50015
Manufacturer CountryIT
Manufacturer Postal Code50015
Single Use3
Remedial ActionRP
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameVIDAS ANALYZER
Generic NameVIDAS ANALYZER
Product CodeDEW
Date Received2016-08-29
Model Number99735
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBIOM?RIEUX ITALIA
Manufacturer AddressVIA DI CAMPIGLIANO 58 PONTE-A EMA FIRENZE, ITALY 50015 IT 50015


Patients

Patient NumberTreatmentOutcomeDate
10 2016-08-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.